97 related articles for article (PubMed ID: 9694355)
1. HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines.
Koopman LA; Mulder A; Corver WE; Anholts JD; Giphart MJ; Claas FH; Fleuren GJ
Tissue Antigens; 1998 Jun; 51(6):623-36. PubMed ID: 9694355
[TBL] [Abstract][Full Text] [Related]
2. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.
Koopman LA; Corver WE; van der Slik AR; Giphart MJ; Fleuren GJ
J Exp Med; 2000 Mar; 191(6):961-76. PubMed ID: 10727458
[TBL] [Abstract][Full Text] [Related]
3. Multiple mechanisms underlie HLA dysregulation in cervical cancer.
Brady CS; Bartholomew JS; Burt DJ; Duggan-Keen MF; Glenville S; Telford N; Little AM; Davidson JA; Jimenez P; Ruiz-Cabello F; Garrido F; Stern PL
Tissue Antigens; 2000 May; 55(5):401-11. PubMed ID: 10885560
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen class I gene mutations in cervical cancer.
Koopman LA; van Der Slik AR; Giphart MJ; Fleuren GJ
J Natl Cancer Inst; 1999 Oct; 91(19):1669-77. PubMed ID: 10511595
[TBL] [Abstract][Full Text] [Related]
5. Interferon-beta and -gamma, but not tumor necrosis factor-alpha, demonstrate immunoregulatory effects on carcinoma cell lines infected with human papillomavirus.
Bornstein J; Lahat N; Kinarty A; Revel M; Abramovici H; Shapiro S
Cancer; 1997 Mar; 79(5):924-34. PubMed ID: 9041155
[TBL] [Abstract][Full Text] [Related]
6. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
[TBL] [Abstract][Full Text] [Related]
7. High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines.
Hurks HM; Metzelaar-Blok JA; Mulder A; Claas FH; Jager MJ
Int J Cancer; 2000 Mar; 85(5):697-702. PubMed ID: 10699951
[TBL] [Abstract][Full Text] [Related]
8. Analysis of HLA-E expression in human tumors.
Marín R; Ruiz-Cabello F; Pedrinaci S; Méndez R; Jiménez P; Geraghty DE; Garrido F
Immunogenetics; 2003 Feb; 54(11):767-75. PubMed ID: 12618909
[TBL] [Abstract][Full Text] [Related]
9. Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.
Ritz U; Momburg F; Pilch H; Huber C; Maeurer MJ; Seliger B
Int J Oncol; 2001 Dec; 19(6):1211-20. PubMed ID: 11713591
[TBL] [Abstract][Full Text] [Related]
10. High frequency of HLA-B44 allelic losses in human solid tumors.
Cabrera T; Maleno I; Lopez-Nevot MA; Redondo M; Fernandez MA; Collado A; Garrido F
Hum Immunol; 2003 Oct; 64(10):941-50. PubMed ID: 14522091
[TBL] [Abstract][Full Text] [Related]
11. Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines.
Méndez R; Rodríguez T; Del Campo A; Monge E; Maleno I; Aptsiauri N; Jiménez P; Pedrinaci S; Pawelec G; Ruiz-Cabello F; Garrido F
Cancer Immunol Immunother; 2008 May; 57(5):719-29. PubMed ID: 17934731
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
Kloth JN; Gorter A; Fleuren GJ; Oosting J; Uljee S; ter Haar N; Dreef EJ; Kenter GG; Jordanova ES
J Pathol; 2008 Jul; 215(3):222-30. PubMed ID: 18438953
[TBL] [Abstract][Full Text] [Related]
13. Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts.
Masuda K; Hiraki A; Fujii N; Watanabe T; Tanaka M; Matsue K; Ogama Y; Ouchida M; Shimizu K; Ikeda K; Tanimoto M
Cancer Sci; 2007 Jan; 98(1):102-8. PubMed ID: 17083564
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas.
Drénou B; Tilanus M; Semana G; Alizadeh M; Birebent B; Grosset JM; Dias P; van Wichen D; Arts Y; De Santis D; Fauchet R; Amiot L
Br J Haematol; 2004 Oct; 127(1):40-9. PubMed ID: 15384976
[TBL] [Abstract][Full Text] [Related]
15. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
[TBL] [Abstract][Full Text] [Related]
16. High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas.
Cabrera T; Collado A; Fernandez MA; Ferron A; Sancho J; Ruiz-Cabello F; Garrido F
Tissue Antigens; 1998 Aug; 52(2):114-23. PubMed ID: 9756399
[TBL] [Abstract][Full Text] [Related]
17. LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.
Maleno I; Romero JM; Cabrera T; Paco L; Aptsiauri N; Cozar JM; Tallada M; López-Nevot MA; Garrido F
Immunogenetics; 2006 Jul; 58(7):503-10. PubMed ID: 16705407
[TBL] [Abstract][Full Text] [Related]
18. High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity.
Rodriguez T; Méndez R; Roberts CH; Ruiz-Cabello F; Dodi IA; López Nevot MA; Paco L; Maleno I; Marsh SG; Pawelec G; Garrido F
Cancer Immunol Immunother; 2005 Feb; 54(2):141-8. PubMed ID: 15592718
[TBL] [Abstract][Full Text] [Related]
19. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at 6p21 and HLA class I expression in esophageal squamous cell carcinomas in China.
Zhao X; Sun Q; Tian H; Cong B; Jiang X; Peng C
Asian Pac J Cancer Prev; 2011; 12(10):2741-5. PubMed ID: 22320985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]